ANTHRAX VACCINE

(ALUM PRECIPITATED ANTHRAX ANTIGENS

This Anthrax Vaccine is a product of the growth of Sterne strain of anthrax bacillus rendered sterile by filtration and containing 0.005% w/v thiomersal as preservative.

DOSE

When Anthrax Vaccine (Alum Precipitated Anthrax Antigens) is used for the active immunisation of man against the various forms of anthrax four doses of 0.5ml should be given intramuscularly. The first three doses should be given at intervals of three weeks, followed by a fourth dose at an interval of six months. Reinforcing doses of 0.5ml intramuscularly should be given annually.

DIRECTIONS FOR USE

This ampoule must be WELL SHAKEN before drawing up the dose in a sterile syringe. Inoculations should be given intramuscularly, preferably in the deltoid muscle, as there is greater risk of local reactions when this vaccine is given subcutaneously.

PRECAUTIONS

Reactions are uncommon but, occasionally, mild erythema or swelling lasting for about two days may occur at the site of inoculation or even at the site of a previous injection of the vaccine. More rarely regional lymphadenopathy, mild febrile reactions, urticaria or other allergic manifestations may occur. The occurrence of a reaction after a first injection does not necessarily indicate a predisposition to subsequent reactions on further injections.

NOTE

When using this vaccine the batch number should be recorded, in the recipients records.

STORAGE

The vaccine should be kept at temperatures between 20C and 80C, freezing must be avoided.

LEGAL CLASS: POM

PL1511/0037 Product Reference No. D.1031


Top of Page Current Section Index